Beneath the bonnet: The case for Yihai International, Jollyes and EM healthcare

Three fund managers on stocks that are whetting their appetite

There are ways investors can benefit from the burgeoning healthcare sector across developing nations, without having to undergo the “challenging” research and development process that drug companies have to endure, according to Aubrey Capital Management’s Mark Martyrossian.

Continue reading here Beneath the bonnet: The case for Yihai International, Jollyes and EM healthcare | Portfolio Adviser